Targeting the chemokines in myocardial inflammation.
Frangogiannis
Nikolaos G
NG
Entman
Mark L
ML
D000818:Animals; D002598:Chagas Cardiomyopathy / Q000188:drug therapy; D054407:Chemokine CCL4; D018946:Chemokine CCL5 / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D018925:Chemokines / Q000037:antagonists & inhibitors* / Q000502:physiology; D019742:Chemokines, CC / Q000037:antagonists & inhibitors / Q000502:physiology; D006801:Humans; D007962:Leukocytes / Q000502:physiology; D019402:Macrophage Inflammatory Proteins / Q000037:antagonists & inhibitors / Q000502:physiology; D051379:Mice; D009205:Myocarditis / Q000188:drug therapy* / Q000378:metabolism
C483024:CCL5 protein, human; D054407:Chemokine CCL4; D018946:Chemokine CCL5; D018925:Chemokines; D019742:Chemokines, CC; D019402:Macrophage Inflammatory Proteins; C108335:RANTES, Met-